You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vemurafenib

Showing 26 - 50 of 186
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hairy Cell Leukemia, Leukemia, Leukemia, Hairy Cell Trial in United States (Vemurafenib, Obinutuzumab)

Active, not recruiting
  • Hairy Cell Leukemia
  • +2 more
  • New Haven, Connecticut
  • +8 more
Feb 7, 2022

Cancer Trial in Melbourne (Trametinib, Cobimetinib, Binimetinib)

Recruiting
  • Cancer
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Nov 4, 2022

Melanoma Metastatic, BRAF V600 Mutation Trial in Italy (Experimental combination beyond Focal Progression, Pembrolizumab or

Active, not recruiting
  • Melanoma Metastatic
  • BRAF V600 Mutation
  • Experimental combination beyond Focal Progression
  • Pembrolizumab or Nivolumab
  • Bari, BA, Italy
  • +13 more
Dec 1, 2021

Colorectal Cancer Trial in Shanghai (VIC, Bevacizumab Plus Chemotherapy)

Recruiting
  • Colorectal Cancer
  • VIC
  • Bevacizumab Plus Chemotherapy
  • Shanghai, China
    Department of General Surgery, Zhongshan Hospital, Fudan Univers
Sep 14, 2022

Melanoma, Melanoma (Skin), Melanoma Stage Trial in Napoli (Vemurafenib, Cobimetinib)

Terminated
  • Melanoma
  • +2 more
  • Napoli, Italy
    Fondazione G.Pascale
Apr 23, 2021

NSCLC Trial in London (MPDL3280A, Vemurafenib, Alectinib)

Recruiting
  • Non-small Cell Lung Cancer
  • London, United Kingdom
    Univeristy College London Hospital
Feb 22, 2022

Metastatic or Locally Advanced Malignancies Trial in Germany (Vemurafenib, Cobimetinib, Atezolizumab)

Recruiting
  • Metastatic or Locally Advanced Malignancies
  • Vemurafenib
  • +7 more
  • Berlin, Germany
  • +5 more
Jan 2, 2023

Immunotherapy Among BRAF-Positive Melanoma Patients Treated in

Completed
  • Metastatic Melanoma
  • East Hanover, New Jersey
    Novartis Investigative Site
Nov 11, 2022

Rare Tumor, Refractory Tumor Trial in Shanghai (Gefitinib, Erlotinib, Afatinib)

Recruiting
  • Rare Tumor
  • Refractory Tumor
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Feb 16, 2022

Cancer, Tumors, Tumors Trial in Denmark (Alectinib, Atezolizumab, Avelumab)

Recruiting
  • Cancer
  • +3 more
  • Aalborg, Denmark
  • +6 more
Oct 25, 2022

Targeted Therapies in BRAF Positive Metastatic Melanoma in US

Active, not recruiting
  • Melanoma
  • New York, New York
    Pfizer Investigational Site
Feb 18, 2022

Colorectal Cancer Metastatic Trial in Guangzhou (Cetuximab, Irinotecan, Vemurafenib)

Recruiting
  • Colorectal Cancer Metastatic
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 7, 2021

Clinical Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +5 more
  • Jacksonville, Florida
  • +2 more
Oct 21, 2022

Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)

Recruiting
  • Advanced Cancer
  • Solid Tumor
  • Helsinki, Uusimaa, Finland
  • +2 more
Jun 8, 2022

Patients With Advanced Refractory Solid Tumors

Not yet recruiting
  • Feasibility
  • +3 more
  • Targeted therapy
  • (no location specified)
Dec 14, 2021

Malignant Melanoma Trial in France, Germany (Vemurafenib, Cobimetinib, Atezolizumab)

Terminated
  • Malignant Melanoma
  • Vemurafenib
  • +2 more
  • Marseille, France
  • +6 more
Jan 29, 2021

Melanoma Trial in Worldwide (Atezolizumab, Atezolizumab Placebo, Cobimetinib)

Active, not recruiting
Has Results
  • Melanoma
  • Birmingham, Alabama
  • +115 more
Jul 11, 2022

Advanced Malignant Tumor, BRAF Gene Mutation, Metastatic Malignant Tumor Trial in Houston (Crizotinib, Laboratory Biomarker

Completed
  • Advanced Malignant Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2021

Melanoma Trial in New York (Vemurafenib)

Terminated
Has Results
  • Melanoma
  • Vemurafenib
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Sep 8, 2020

Solid Tumor, Lymphoma Trial in Worldwide (CX-072, ipilimumab, vemurafenib)

Completed
  • Solid Tumor
  • Lymphoma
  • Los Angeles, California
  • +30 more
Feb 7, 2022

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Edmonton, Alberta, Canada
  • +9 more
Jan 9, 2023

BRAF Mutant Metastatic Melanoma Trial in San Francisco (BKM120 Combined with Vemurafenib (PLX4032))

Completed
Has Results
  • BRAF Mutant Metastatic Melanoma
  • BKM120 Combined with Vemurafenib (PLX4032)
  • San Francisco, California
    University of California, San Francisco
Aug 6, 2020

Metastatic Melanoma Trial in United States (vemurafenib + HD IL-2)

Terminated
  • Metastatic Melanoma
  • vemurafenib + HD IL-2
  • Tucson, Arizona
  • +20 more
Jan 28, 2021

Cancer Metastatic Trial in Norway (Atezolizumab)

Recruiting
  • Cancer Metastatic
  • Bergen, Norway
  • +16 more
Oct 24, 2022

Advanced Cancers Trial in Houston (Vemurafenib, Carboplatin, Paclitaxel)

Completed
  • Advanced Cancers
  • Vemurafenib
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 18, 2020